SCHEMBL719258

SCHEMBL719258

FC(F)=CCCSc1ncccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.41
NPC1 O15118 9/20 0.41
KMT2A Q03164 4/20 0.38
KDM1A O60341 2/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 6/20 0.38
MAPT P10636 5/20 0.38
MAPK1 P28482 4/20 0.38
HPGD P15428 3/20 0.38
TP53 P04637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 2/20 0.37
ALDH1A1 P00352 3/20 0.37
HTT P42858 2/20 0.35
TDP1 Q9NUW8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7029648 0.83
SCHEMBL7019151 0.82 NPC1 (0.30) RAB9ANPC1
SCHEMBL5928189 0.80 ALDH1A1 (0.33) KMT2AHPGDNPSR1ALDH1A1L3MBTL1
SCHEMBL8752023 0.80 ALDH1A1 (0.41) RAB9ANPC1KMT2AMEN1CYP1A2
SCHEMBL5928179 0.80 KDM4E (0.40) RAB9ANPC1KMT2AMEN1CYP1A2
SCHEMBL7019138 0.79 ALDH1A1 (0.53) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL8752043 0.79 ALOX15 (0.51) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL5928298 0.79 NPSR1 (0.35) RAB9ANPC1KMT2ASMN1; SMN2NPSR1
SCHEMBL7015079 0.78
SCHEMBL7620884 0.77 DUSP10 (0.51) KMT2AMEN1SMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765774-B2 3-arylquinazolin-4-one compounds for combating invertebrate pests BASF SE (DE) 2014-07-01 US disclosed
EP-2403837-B1 3-ARYLQUINAZOLIN-4-ONE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2013-12-11 EP disclosed
US-20120053052-A1 3-Arylquinazolin-4-one compounds for combating invertebrate pests BASF SE (DE) 2012-03-01 US disclosed
EP-2403837-A1 3-ARYLQUINAZOLIN-4-ONE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2012-01-11 EP disclosed
WO-2010100189-A1 3-ARYLQUINAZOLIN-4-ONE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2010-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053052-A1 3-Arylquinazolin-4-one compounds for combating invertebrate pests CBR3, CNPY3, RTN3 RAB9A 3593/4885NPC1 1409/4885KMT2A 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.